P. VENUNGOPAL, K. BALAKRISHNAN, D. K. SRIRAM, and M. GEORGE, “INCLISIRAN (LEQVIO): A FIRST-IN-CLASS SMALL INTERFERING RNA THERAPEUTIC DRUG APPROVED BY FDA FOR TREATING PRIMARY HYPERCHOLESTEROLEMIA OR DYSLIPIDEMIA”, Asian J Pharm Clin Res, vol. 15, no. 12, pp. 42–46, Dec. 2022.